Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
$52.72
-0.32 (-0.60%)
| CAPS Rating |
|
|---|---|
| Open | $52.74 |
| Previous Close | $53.04 |
| Daily Range | $52.50 - $53.08 |
| 52-Week Range | $39.75 - $54.95 |
| Market Cap | $48.08B |
| P/E Ratio | 54.12 |
| Dividend (Yield) | 0.48 (0.90%) |
| Volume | 4,089,937 |
| Average Daily Volume | 4,556,000 |
How do you think TEVA will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
TEVA Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
TEVA News and Commentary
- EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix – SmartMoney
- Pfizer's Generic Growth, With a Side of Sashimi – The Motley Fool
- In Search of Dividends...and More – SmartMoney
- American Funds' Achilles' Heel – The Motley Fool
- DARA Set to Sky Rocket by Thursday – Blog at The Motley Fool
- Are You Ready to Make Real Money? – The Motley Fool
- When Big Tax Breaks Aren't Worth the Hassle – The Motley Fool
- The Life-and-Death Situation That Isn't – The Motley Fool
- Powerfully Performing ADRs – The Motley Fool
- Second Round Bids For Ratiopharm Due Mid-December - Source – SmartMoney
- XNPT is on the move – Blog at The Motley Fool
- MFI Stock Review: Cephalon (CEPH) – Blog at The Motley Fool
- CNBC on Teva Pharmaceutical Industries Limited – Ockham-RazorWire
- CNBC on Teva Pharmaceutical Industries Limited – Ockham-RazorWire
- Nice Quarter, Teva. What Will You Buy Next? – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- BRIEF-Teva Pharmaceutical 2009, 2010 EPS outlook – Reuters
- UPDATE 1-Teva Q3 profit higher as Copaxone sales jump – Reuters
- Finally Convinced? Benlysta Works! – The Motley Fool
- Winners and Losers of the House Health-Care Reform Bill – The Motley Fool


RSS Headlines
Fool UK